This is the first prospective study using next-generation sequencing to detect the microbial composition of the faeces of rhabdomyosarcoma-bearing APN−/− and wild-type mice, and it highlights that the gut microbiota may be a potential target of APN deficiency against rhabdomyosarcoma. This evidence concerns the gene ANPEP and rhabdomyosarcoma.